Infliximab therapy in children with Crohn's disease: a one-year evaluation of efficacy comparing 'top-down' and 'step-up' strategies

Acta Paediatrica
Mi Jin KimYon Ho Choe

Abstract

The aim of this study was to evaluate the efficacy of 'top-down' regimens for the treatment of paediatric Crohn's disease (CD) and to compare it with the effects of 'step-up' treatment. We evaluated patients treated with 'top-down' and 'step-up' regimens at 8 weeks after the initiation of treatment, with 1 year of follow-up. Of the 29 patients who received infliximab, 11 cases refractory to conventional therapy were categorized as the 'step-up' group; and 18 cases, with moderate to severe CD, were categorized as the 'top-down' group. Treatment efficacy was assessed by Pediatric Crohn's Disease Activity Index (PCDAI) scores. At 8 weeks, remission was achieved in three of 11 patients in the 'step-up' group and 16 of 18 patients in the 'top-down' group. At 1 year, remission was maintained in five of 11 patients and in 15 of 18 patients, in the 'step-up' and 'top-down' groups, respectively. The serum albumin level, erythrocyte sedimentation rate, PCDAI score and perianal fistula status demonstrated significant improvement in the 'top-down' group. In paediatric patients with CD, the infliximab 'top-down' strategy resulted in superior outcomes when compared to the 'step-up' strategy for inducing and maintaining remission at 8 weeks a...Continue Reading

References

Feb 25, 1999·Gastroenterology·A OtleyA M Griffiths
Aug 10, 2000·The Journal of Pediatrics·J S HyamsR Wyllie
Jun 6, 2002·Lancet·Stephen B HanauerUNKNOWN ACCENT I Study Group
Jan 16, 2003·The American Journal of Gastroenterology·Michael C StephensRobert N Baldassano
May 10, 2003·The American Journal of Gastroenterology·Robert BaldassanoHarland S Winter
Feb 6, 2004·Gastroenterology·Paul RutgeertsStephen B Hanauer
Aug 21, 2004·Journal of Pediatric Gastroenterology and Nutrition·Craig A FriesenCharles C Roberts
Jul 2, 2005·Journal of Pediatric Gastroenterology and Nutrition·UNKNOWN IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition
Oct 6, 2005·Journal of Pediatric Gastroenterology and Nutrition·Jeffrey HyamsUNKNOWN Pediatric Inflammatory Bowel Disease Collaborative Research Group
Jul 5, 2008·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·A ArmuzziA Gasbarrini
Aug 30, 2008·Gastroenterology·Johan Van LimbergenDavid C Wilson
Dec 25, 2008·Inflammatory Bowel Diseases·Jeffrey S HyamsUNKNOWN Pediatric Inflammatory Bowel Disease Collaborative Research Group
Feb 7, 2009·Zeitschrift für Gastroenterologie·J Meier, A Sturm
Nov 17, 2009·Gastroenterology Clinics of North America·Shane M Devlin, Remo Panaccione

❮ Previous
Next ❯

Citations

Jul 26, 2012·Current Opinion in Pediatrics·Linda S YangAnthony G Catto-Smith
Aug 21, 2013·Nature Reviews. Gastroenterology & Hepatology·Marina AloiSalvatore Cucchiara
Jul 5, 2011·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·C WantyF Smets
Jan 28, 2014·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Parambir S DulaiCorey A Siegel
Jul 23, 2014·Paediatric Drugs·Federica NutiSalvatore Cucchiara
Jul 28, 2015·Expert Review of Clinical Immunology·Federica NutiSilvio Danese
Feb 11, 2016·International Journal of Molecular Sciences·Rocío Prieto-PérezFrancisco Abad-Santos
Nov 25, 2014·Expert Opinion on Pharmacotherapy·Andrea AffrontiMario Cottone
Dec 7, 2011·Gastroenterology Research and Practice·Oliver GouldthorpeGeorge Alex
Mar 8, 2017·Journal of Pediatric Gastroenterology and Nutrition·Jorge Amil-DiasUNKNOWN IBD Working Group of ESPGHAN (IBD Porto Group)
Jul 23, 2013·Inflammatory Bowel Diseases·Parambir S DulaiMarla C Dubinsky
Jan 14, 2018·Clinical Pharmacokinetics·Amy Hemperly, Niels Vande Casteele
Sep 7, 2013·Pediatric Gastroenterology, Hepatology & Nutrition·Yun Seok LeeYon Ho Choe
Apr 2, 2019·Inflammatory Bowel Diseases·Dana Rachel BergRyan Ungaro
Oct 13, 2012·Journal of Pediatric Gastroenterology and Nutrition·Ellen A LipsteinMaria T Britto
Aug 27, 2013·Journal of Pediatric Gastroenterology and Nutrition·Edwin F de ZoetenHoward A Kader
Nov 28, 2016·Indian Pediatrics·Akshay KapoorAnupam Sibal
Aug 17, 2020·Paediatric Drugs·Karen van Hoeve, Séverine Vermeire
Jun 3, 2015·World Journal of Gastroenterology : WJG·Colin T Baillie, Jennifer A Smith
Apr 29, 2021·Journal of Pediatric Gastroenterology and Nutrition·Mi Jin KimYon Ho Choe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

World Journal of Gastroenterology : WJG
Jong Seung LeeYon Ho Choe
Inflammatory Bowel Diseases
Jeffrey S HyamsPediatric Inflammatory Bowel Disease Collaborative Research Group
Journal of Pediatric Gastroenterology and Nutrition
Craig A FriesenCharles C Roberts
© 2021 Meta ULC. All rights reserved